Functional microRNAs in Alzheimer's disease and cancer: Differential regulation of common mechanisms and pathways

Frontiers in Genetics

Volumn 3, Issue JAN, 2013, Pages

  Holohan, Kelly N ^a,b   Lahiri, Debomoy K ^a   Schneider, Bryan P ^a,c   Foroud, Tatiana ^a   Saykin, Andrew J ^a,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF NURSING   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Cancer; Microrna; Pathways

Indexed keywords

EID: 84876182823     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2012.00323     Document Type: Review

References (185)

1. Alpini, G., Glaser, S. S., Zhang, J. P., Francis, H., Han, Y., Gong, J., etal. (2011). Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer. J. Hepatol. 55, 1339-1345.
2. Au, S. L., Wong, C. C., Lee, J. M., Fan, D. N., Tsang, F. H., Ng, I. O., etal. (2012). Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microR-NAs to promote liver cancer metastasis. Hepatology 56, 622-631.
3. Banerjee, R., Mani, R. S., Russo, N., Scanlon, C. S., Tsodikov, A., Jing, X., etal. (2011). The tumor suppressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in invasive squamous cell carcinoma. Oncogene 30, 4339-4349.
4. Bao, B., Ali, S., Banerjee, S., Wang, Z., Logna, F., Azmi, A. S., etal. (2012). Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression. Cancer Res. 72, 335-345.
5. Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116,281-297.
6. Bhaumik, D., Scott, G. K., Schokrpur, S., Patil, C. K., Campisi, J., and Benz, C. C. (2008). Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene 27, 5643-5647.
7. Biessels, G. J., and Kappelle, L. J. (2005). Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem. Soc. Trans. 33, 1041-1044.
8. Biessels, G. J., Staekenborg, S., Brun-ner, E., Brayne, C., and Scheltens, P. (2006). Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 5, 64-74.
9. Biron, K. E., Dickstein, D. L., Gopaul, R., and Jefferies, W A. (2011). Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervas-cularity in Alzheimer's disease. PLoS ONE 6:e23789. doi: 10.1371/jour-nal.pone.0023789
10. Borgesius, N. Z., De Waard, M. C., Van Der Pluijm, I., Omrani, A., Zondag, G. C., Van Der Horst, G. T., etal. (2011). Accelerated age-related cognitive decline and neurodegenera-tion, caused by deficient DNA repair. J. Neurosci. 31,12543-12553.
11. Braconi, C., Kogure, T., Valeri, N., Huang, N., Nuovo, G., Costinean, S., etal. (2011). microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 30, 4750-4756.
12. Bruneau, S., Datta, D., Flaxenburg, J. A., Pal, S., and Briscoe, D. M. (2012). TRAF6 inhibits proangiogenic signals in endothelial cells and regulates the expression of vascular endothelial growth factor. Biochem. Biophys. Res. Commun. 419, 66-71.
13. Bryant, R. J., Pawlowski, T., Catto, J. W., Marsden, G., Vessella, R. L., Rhees, B., etal. (2012). Changes in circulating microRNA levels associated with prostate cancer. Br. J. Cancer 106, 768-774.
14. Bushati, N., and Cohen, S. M. (2008). MicroRNAs in neurodegen-eration. Curr. Opin. Neurobiol. 18, 292-296.
15. Cameron, D. J., Galvin, C., Alkam, T., Sidhu, H., Ellison, J., Luna, S., etal. (2012). Alzheimer's-related peptide amyloid-β plays a conserved role in angiogenesis. PLoS ONE 7:e39598. doi: 10.1371/journal.pone.0039598
16. Carvalho, J., Van Grieken, N. C., Pereira, P. M., Sousa, S., Tijssen, M., Buf-fart, T. E., etal. (2012). Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer. J. Pathol. 228, 31-44.
17. Chen-Plotkin, A. S., Unger, T. L., Gallagher, M. D., Bill, E., Kwong, L. K., Volpicelli-Daley, L., etal. (2012). TMEM106B, the risk gene for fron-totemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways. J. Neu-rosci. 32, 11213-11227.
18. Chen, P. S., Su, J. L., Cha, S. T., Tarn, W. Y., Wang, M. Y., Hsu, H. C., etal. (2011). miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans. J. Clin. Invest. 121, 3442-3455.
19. Chendrimada, T. P., Gregory, R. I., Kumaraswamy, E., Norman, J., Cooch, N., Nishikura, K., etal. (2005). TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436, 740-744.
20. Cogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., etal. (2008). Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J. Alzheimers Dis. 14,27-41.
21. Cole, S. W., and Sood, A. K. (2012). Molecular pathways: beta-adrenergic signaling in cancer. Clin. Cancer Res. 18,1201-1206.
22. Craft, S. (2007). Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. Curr. Alzheimer Res. 4,147-152.
23. Cui, J. G., Li, Y Y, Zhao, Y., Bhattachar-jee, S., and Lukiw, W J. (2010). Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease. J. Biol. Chem. 285, 38951-38960.
24. Datta, J., Smith, A., Lang, J. C., Islam, M., Dutt, D., Teknos, T. N., etal. (2011). microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cε. Oncogene 31, 4045-4053.
25. De Leon, M. J., George, A. E., Golomb, J., Tarshish, C., Convit, A., Kluger, A., etal. (1997). Frequency of hip-pocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol. Aging 18, 1-11.
26. Desikan, R. S., Sabuncu, M. R., Schman-sky, N. J., Reuter, M., Cabral, H. J., Hess, C. P., etal. (2010). Selective disruption of the cerebral neo-cortex in Alzheimer's disease. PLoS ONE 5:e12853. doi: 10.1371/jour-nal.pone.0012853
27. Ding, Q., Chang, C. J., Xie, X., Xia, W., Yang, J. Y., Wang, S. C., etal. (2011). APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis.J. Clin. Invest. 121, 4526-4536.
28. Driver, J. A., Beiser, A., Au, R., Kreger, B. E., Splansky, G. L., Kurth, T., etal. (2012). Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study. BMJ 344, e1442.
29. Driver, J. A., and Lu, K. P. (2010). Pin1: a new genetic link between Alzheimer's disease, cancer and aging. Curr. Aging Sci. 3,158-165.
30. Fabbri, M., Garzon, R., Cimmino, A., Liu, Z., Zanesi, N., Callegari, E., et al. (2007). MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. U.S.A. 104, 15805-15810.
31. Fang, J. H., Zhou, H. C., Zeng, C., Yang, J., Liu, Y., Huang, X., etal. (2011). MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix met-alloproteinase 2 expression. Hepatol-ogy 54, 1729-1740.
32. Fei,X.,Qi,M.,Wu,B.,Song,Y.,Wang,Y., and Li, T. (2012). MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression. FEBSLett. 586, 392-397.
33. Feng, L., Xie, Y., Zhang, H., and Wu, Y (2012). miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells. Med. Oncol. 29, 856-863.
34. Flavin, R. J., Smyth, P. C., Laios, A., O'Toole, S. A., Barrett, C., Finn, S. P., etal. (2009). Potentially important microRNA cluster on chromosome 17p 13.1 in primary peritoneal carcinoma. Mod. Pathol. 22,197-205.
35. Formosa, A., Lena, A. M., Markert, E. K., Cortelli, S., Miano, R., Mauriello, A., etal. (2012). DNA methylation silences miR-132 in prostate cancer. Oncogene. doi: 10.1038/onc.2012.14 [Epub ahead of print].
36. Garzon, R., Calin, G. A., and Croce, C. M. (2009a). MicroRNAs in cancer. Annu. Rev. Med. 60, 167-179.
37. Garzon, R., Heaphy, C. E., Havelange, V., Fabbri, M., Volinia, S., Tsao, T., etal. (2009b). MicroRNA 29b functions in acute myeloid leukemia. Blood 114, 5331-5341.
38. Gascon, E., and Gao, F. B. (2012). Cause or effect: misregula-tion of microRNA pathways in neurodegeneration. Front. Neurosci. 6:48. doi: 10.3389/fnins.2012.00048
39. Glenner, G. G.,Wong, C. W (1984). Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Com-mun. 120,885-890.
40. Gregory, R. I., Chendrimada, T. P., Cooch, N., and Shiekhattar, R. (2005). Human RISC couples microRNA biogenesis and posttran-scriptional gene silencing. Cell 123, 631-640.
41. Gregory, R. I., Yan, K. P., Amuthan, G., Chendrimada, T., Doratotaj, B., Cooch, N., etal. (2004). The microprocessor complex mediates the genesis of microRNAs. Nature 432, 235-240.
42. Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., and Binder, L. I. (1986). Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U.S.A. 83, 4913-4917.
43. Guled, M., Lahti, L., Lindholm, P. M., Salmenkivi, K., Bagwan, I., Nicholson, A. G., etal. (2009). CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma - a miRNA microarray analysis. Genes Chromosomes Cancer 48, 615-623.
44. Guo, S. T., Jiang, C. C., Wang, G. P., Li, Y. P., Wang, C. Y., Guo, X. Y., etal. (2012). MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppres-sive role in human colorectal cancer. Oncogene. doi: 10.1038/onc.2012.214 [Epub ahead of print].
45. Gustaw-Rothenberg, K., Lerner, A., Bonda, D. J., Lee, H. G., Zhu, X., Perry, G., etal. (2010). Biomarkers in Alzheimer's disease: past, present and future. Biomark. Med. 4,15-26.
46. Hanahan, D., and Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100,57-70.
47. Hao, Y., Gu, X., Zhao, Y., Greene, S., Sha, W., Smoot, D. T., etal. (2011). Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo. Cancer Prev. Res. (Phila) 4, 1073-1083.
48. Hebert, S. S., Horre, K., Nico-lai, L., Papadopoulou, A. S., Mandemakers, W., Silahtaroglu, A. N., etal. (2008). Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. U.S.A. 105, 6415-6420.
49. Hedskog, L., Zhang, S., and Ankarcrona, M. (2012). Strategic role for mitochondria in Alzheimer's disease and cancer. Antioxid. Redox Signal. 16, 1476-1491.
50. Heneghan, H. M., Miller, N., Kelly, R., Newell, J., and Kerin, M. J. (2010a). Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. Oncologist 15,673-682.
51. Heneghan, H. M., Miller, N., Low-ery, A. J., Sweeney, K. J., Newell, J., and Kerin, M. J. (2010b). Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann.Surg. 251,499-505.
52. Hiroki, E., Akahira, J., Suzuki, F., Nagase, S., Ito, K., Suzuki, T., etal. (2010). Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas. Cancer Sci. 101, 241-249.
53. Ho, L., Pieroni, C., Winger, D., Purohit, D. P., Aisen, P. S., and Pasinetti, G. M. (1999). Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease. J. Neurosci. Res. 57, 295-303.
54. Huang, L., Luo, J., Cai, Q., Pan, Q., Zeng, H., Guo, Z., et al. (2011). MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. Int. J. Cancer 128, 1758-1769.
55. Hurst, D. R., Edmonds, M. D., Scott, G. K., Benz, C. C., Vaidya, K. S., and Welch, D. R. (2009). Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res. 69,1279-1283.
56. Inoue, T., Iinuma, H., Ogawa, E., Inaba, T., and Fukushima, R. (2012). Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer. Oncol. Rep. 27, 1759-1764.
57. Jack, C. R. Jr., Petersen, R. C., Xu, Y., O'Brien, P. C., Smith, G. E., Ivnik, R. J., etal. (1998). Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology 51,993-999.
58. Jeppesen, D. K., Bohr, V. A., and Stevn-sner, T. (2011). DNA repair deficiency in neurodegeneration. Prog. Neurobiol. 94, 166-200.
59. John, B., Sander, C., and Marks, D. S. (2006). Prediction of human microRNA targets. Methods Mol. Biol.342, 101-113.
60. Kim, T. H., Kim, Y. K., Kwon, Y., Heo, J. H., Kang, H., Kim, G., etal. (2010). Deregulation of miR-519a, 153, and 485-5p and its clinicopatho-logical relevance in ovarian epithelial tumours. Histopathology 57, 734-743.
61. Kim, V. N., Han, J., and Siomi, M. C. (2009). Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 10, 126-139.
62. Kole, A. J., Swahari, V., Hammond, S. M., and Deshmukh, M. (2011). miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis. Genes Dev. 25, 125-130.
63. Kosik, K. S., Joachim, C. L., and Selkoe, D. J. (1986). Microtubule-associated protein tau (tau) is a major anti-genic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 83,4044-4048.
64. Kottakis, F., Polytarchou, C., Foltopoulou, P., Sanidas, I., Kampra-nis, S. C., and Tsichlis, P. N. (2011). FGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1/KDM2B-miR-101-EZH2 pathway. Mol. Cell 43, 285-298.
65. Krek, A., Grun, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., etal. (2005). Combinatorial microRNA target predictions. Nat. Genet. 37, 495-500.
66. Krell, J., Frampton, A. E., Jacob, J., Pelle-grino, L., Roca-Alonso, L., Zeloof, D., etal. (2012). The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasis. Mol. Diagn. Ther. 16,167-172.
67. Krichevsky, A. M., Sonntag, K. C., Isacson, O., and Kosik, K. S. (2006). Specific microRNAs modulate embryonic stem cell-derived neu-rogenesis. Stem Cells 24, 857-864.
68. Lakomy, R., Sana, J., Hankeova, S., Fadrus, P., Kren, L., Lzicarova, E., etal. (2011). MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients. Cancer Sci. 102,2186-2190.
69. Lau, P., and de Strooper, B. (2010). Dys-regulated microRNAs in neurode-generative disorders. Semin. Cell Dev. Biol. 21,768-773.
70. Lee, K. H., Lotterman, C., Karikari, C., Omura, N., Feldmann, G., Habbe, N., etal. (2009). Epigenetic silencing of microRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology 9, 293-301.
71. Leucci, E., Zriwil, A., Gregersen, L. H., Jensen, K. T., Obad, S., Bellan, C., etal. (2012). Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo. Oncogene 31, 5081-5089.
72. Leuner, K., Muller, W. E., and Reichert, A. S. (2012). From mitochondrial dysfunction to amyloid beta formation: novel insights into the patho-genesis of Alzheimer's disease. Mol. Neurobiol. 46, 186-193.
73. Li, D., Zhao, Y., Liu, C., Chen, X., Qi, Y., Jiang, Y., etal. (2011a). Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. Clin. Cancer Res. 17, 1722-1730.
74. Li, F., Huang, X. P., Wang, Z. Q., Liu, F. R., Zhou, X. H., Zhong, L., etal. (2011b). Expression of miR-9 in B lymphocytes and B cell lym-phomas cell lines and its significance. Zhonghua Xue Ye Xue Za Zhi 32, 249-253.
75. Li,X.,Zhang, Y., Shi, Y., Dong, G., Liang, J., Han, Y., etal. (2011c). MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer. J. Cell. Mol. Med. 15, 1887-1895.
76. Li, Y., Vandenboom, T. G., 2nd, Wang, Z., Kong, D., Ali, S., Philip, P. A., et al. (2010). miR-146a suppresses invasion of pancreatic cancer cells. Cancer Res. 70, 1486-1495.
77. Li, Y., Wang, F., Xu, J., Ye, F., Shen, Y., Zhou, J., etal. (2011d). Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J. Pathol. 224, 484-495.
78. Li, Y Y., Alexandrov, P. N., Pogue, A. I., Zhao, Y., Bhattacharjee, S., and Lukiw, W. J. (2012). miRNA-155 upregulation and complement factor H deficits in Down's syndrome. Neuroreport 23, 168-173.
79. Lian, H., Wang, L., and Zhang, J. (2012). Increased risk of breast cancer associated with CC genotype of Has-miR-146a Rs2910164 polymorphism in Europeans. PLoS ONE 7:e31615. doi: 10.1371/journal.pone.0031615
80. Liang, L., Wong, C. M., Ying, Q., Fan, D. N., Huang, S., Ding, J., etal. (2010). MicroRNA-125b sup-pressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2. Hepa-tology 52,1731-1740.
81. Lin, S. L., Chiang, A., Chang, D., and Ying, S. Y (2008). Loss of mir-146a function in hormone-refractory prostate cancer. RNA 14, 417-424.
82. Lin, Y., Wu, J., Chen, H., Mao, Y., Liu, Y., Mao, Q., etal. (2012). Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells. FEBSLett. 586,442-447.
83. Liu, L., Chen, L., Xu, Y., Li, R., and Du, X. (2010). microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. Biochem. Biophys. Res. Commun. 400,236-240.
84. Liu, N., Sun, Q., Chen, J., Li, J., Zeng, Y., Zhai, S., etal. (2012a). MicroRNA-9 suppresses uveal melanoma cell migration and invasion through the NF-kappaB1 pathway. Oncol. Rep. 28, 961-968.
85. Liu, S., Kumar, S. M., Lu, H., Liu, A., Yang, R., Pushparajan, A., etal. (2012b). MicroRNA-9 up-regulates E-cadherin through inhibition of NF-kappaB1-Snail 1 pathway in melanoma. J. Pathol. 226, 61-72.
86. Liu, X., Zou, L., Zhu, L., Zhang, H., Du, C., Li, Z., etal. (2012c). miRNA mediated up-regulation of cochaperone p23 acts as an anti-apoptotic factor in childhood acute lymphoblastic leukemia. Leuk. Res. 36, 1098-1104.
87. Long, J. M., and Lahiri, D. K. (2011). MicroRNA-101 downregu-lates Alzheimer's amyloid-beta precursor protein levels in human cell cultures and is differentially expressed. Biochem. Biophys. Res. Commun. 404, 889-895.
88. Long, J. M., Ray, B., and Lahiri, D. K. (2012). MicroRNA-153 physiologically inhibits expression of amyloid-beta precursor protein in cultured human fetal brain cells and is dys-regulated in a subset of Alzheimer disease patients. J. Biol. Chem. 28, 31298-31310.
89. Lukiw, W J. (2004). Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling. Neurochem. Res. 29, 1287-1297.
90. Lukiw, W. J. (2007). Micro-RNA speci-ation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport 18,297-300.
91. Lukiw, W. J. (2012). NF-small ka, CyrillicB-regulated micro RNAs (miRNAs) in primary human brain cells. Exp. Neurol. 235, 484-490.
92. Lukiw, W J., and Alexandrov, P. N. (2012). Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain. Mol. Neurobiol. 46, 11-19.
93. Lukiw, W. J., Surjyadipta, B., Dua, P., and Alexandrov, P. N. (2012). Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in age-related macular degeneration (AMD). Int. J. Biochem. Mol. Biol. 3, 105-116.
94. Lukiw, W. J., Zhao, Y., and Cui, J. G. (2008). An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J. Biol. Chem. 283, 31315-31322.
95. Luo, L., Zhang, T., Liu, H., Lv, T., Yuan, D., Yao, Y., etal. (2012). MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance. Med. Oncol. 29, 1681-1686.
96. Maccioni, R. B., Rojo, L. E., Fernandez, J. A., and Kuljis, R. O. (2009). The role of neuroimmunomodulation in Alzheimer's disease. Ann. N. Y. Acad. Sci. 1153,240-246.
97. Man, Y G., Fu, S. W., Liu, A. J., Sto-jadinovic, A., Izadjoo, M. J., Chen, L., etal. (2011). Aberrant expression of chromogranin A, miR-146a, and miR-146b-5p in prostate structures with focally disrupted basal cell layers: an early sign of invasion and hormone-refractory cancer? Cancer Genomics Proteomics 8,235-244.
98. Maniataki, E., and Mourelatos, Z. (2005). A human, ATP-independent, RISC assembly machine fueled by pre-miRNA. Genes Dev. 19, 2979-2990.
99. Minones-Moyano, E., Porta, S., Escaramis, G., Rabionet, R., Iraola, S., Kagerbauer, B., etal. (2011). MicroRNA profiling of Parkinson's disease brains identifies early down-regulation of miR-34b/c which modulate mitochondrial function. Hum. Mol. Genet. 20, 3067-3078.
100. Minor, J., Wang, X., Zhang, F., Song, J., Jimeno, A., Wang, X. J., etal. (2012). Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squa-mous cell carcinomas. Oral Oncol. 48, 73-78.
101. Mohsenzadegan, M., and Mirshafiey, A. (2012). The immunopathogenic role of reactive oxygen species in Alzheimer disease. Iran. J. Allergy Asthma Immunol. 11,203-216.
102. Moser, J. J., and Fritzler, M. J. (2010). The microRNA and messengerRNA profile of the RNA-induced silencing complex in human primary astro-cyte and astrocytoma cells. PLoS ONE 5:e13445. doi: 10.1371/jour-nal.pone.0013445
103. Mott, J. L., Kobayashi, S., Bronk, S. F., and Gores, G. J. (2007). mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26, 6133-6140.
104. Muramatsu, F., Kidoya, H., Naito, H., Sakimoto, S., and Takakura, N. (2012). microRNA-125b inhibits tube formation of blood vessels through translational suppression of VE-cadherin. Oncogene. doi: 10.1038/onc.2012.68 [Epub ahead of print].
105. Myatt, S. S., Wang, J., Monteiro, L. J., Christian, M., Ho, K. K., Fusi, L., etal. (2010). Definition of microR-NAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res. 70, 367-377.
106. Nath, S., Agholme, L., Kurudenkandy, F. R., Granseth, B., Marcusson, J., and Hallbeck, M. (2012). Spreading of neurodegenerative pathology via neuron-to-neuron transmission of beta-amyloid. J. Neurosci. 32, 8767-8777.
107. Nelson, P. T., and Wang, W X. (2010). MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study. J. Alzheimers Dis. 21, 75-79.
108. Nguyen, T., Kuo, C., Nicholl, M. B., Sim, M. S., Turner, R. R., Morton, D. L., etal. (2011). Downregula-tion of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma. Epigenetics 6, 388-394.
109. Nunez-Iglesias, J., Liu, C. C., Morgan, T. E., Finch, C. E., and Zhou, X. J. (2010). Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation. PLoS ONE 5:e8898. doi: 10.1371/jour-nal.pone.0008898
110. Ono, M. (2008). Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci. 99,1501-1506.
111. Ozata, D. M., Caramuta, S., Velazquez-Fernandez, D., Akcakaya, P., Xie, H., Hoog, A., etal. (2011). The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. Endocr. Relat. Cancer 18, 643-655.
112. Pacifico, F., Crescenzi, E., Mel-lone, S., Iannetti, A., Porrino, N., Liguoro, D., etal. (2010). Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a. J. Clin. Endocrinol. Metab. 95, 1421-1430.
113. Pavlides, S., Tsirigos, A., Vera, I., Flomenberg, N., Frank, P. G., Casimiro, M. C., etal. (2010). Tran-scriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling." Aging (Albany NY) 2, 185-199.
114. Perdahl, E., Adolfsson, R., Alafuzoff, I., Albert, K. A., Nestler, E. J., Green-gard, P., etal. (1984). Synapsin I (protein I) in different brain regions in senile dementia of Alzheimer type and in multi-infarct dementia. J. Neural Transm. 60, 133-141.
115. Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., et al. (2004). NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431, 461-466.
116. Qin, S., Hu, X. Y., Xu, H., and Zhou, J. N. (2004). Regional alteration of synapsin I in the hippocampal formation of Alzheimer's disease patients. Acta Neuropathol. 107,209-215.
117. Qiu, C., Kivipelto, M., and Von Strauss, E. (2009). Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin. Neurosci. 11,111-128.
118. Qiu, L. X., He, J., Wang, M. Y., Zhang, R. X.,Shi,T.Y.,Zhu,M. L.,etal. (2011). The association between common genetic variant of microRNA-146a andcancer susceptibility. Cytokine56, 695-698.
119. Roe, C. M., Behrens, M. I., Xiong, C., Miller, J. P., and Morris, J. C. (2005). Alzheimer disease and cancer. Neurology 64, 895-898.
120. Roe, C. M., Fitzpatrick, A. L., Xiong, C., Sieh, W., Kuller, L., Miller, J. P., etal. (2010). Cancer linked to Alzheimer disease but not vascular dementia. Neurology 74, 106-112.
121. Rojo, L. E., Fernandez, J. A., Maccioni, A. A., Jimenez, J. M., and Maccioni, R. B. (2008). Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease. Arch. Med. Res. 39, 1-16.
122. Rusca, N., and Monticelli, S. (2011). MiR-146a in immunity and disease. Mol Biol.Int. 2011,437301.
123. Schonrock, N., Matamales, M., Ittner, L. M., and Gotz, J. (2012). MicroRNA networks surrounding APP and amyloid-beta metabolism - implications for Alzheimer's disease. Exp. Neurol. 235, 447-454.
124. Schraivogel, D., Weinmann, L., Beier, D., Tabatabai, G., Eichner, A., Zhu, J. Y., etal. (2011). CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells. EMBOJ. 30, 4309-4322.
125. Schreiber, R. D., Old, L. J., and Smyth, M. J. (2011). Cancer immunoedit-ing: integrating immunity's roles in cancer suppression and promotion. Science 331,1565-1570.
126. Segal, E., Friedman, N., Kaminski, N., Regev, A., and Koller, D. (2005). From signatures to models: understanding cancer using microarrays. Nat. Genet. 37(Suppl.),S38-S45.
127. Segal, E., Friedman, N., Koller, D., and Regev, A. (2004). A module map showing conditional activity of expression modules in cancer. Nat. Genet. 36, 1090-1098.
128. Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., etal. (1994). Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. U.S.A. 91, 12013-12017.
129. Semaan, A., Qazi, A. M., Seward, S., Chamala, S., Bryant, C. S., Kumar, S., etal. (2011). MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-mediated transcriptional repression of p21(waf1/cip1). Pharm. Res. 28, 3079-3090.
130. Sethi, G., Shanmugam, M. K., Ramachandran, L., Kumar, A. P., and Tergaonkar, V (2012). Multifaceted link between cancer and inflammation. Biosci. Rep. 32, 1-15.
131. Sethi, P., and Lukiw, W J. (2009). Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex. Neurosci. Lett. 459, 100-104.
132. Shigehara, K., Yokomuro, S., Ishibashi, O., Mizuguchi, Y., Arima, Y., Kawahigashi, Y., etal. (2011). Realtime PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer. PLoS ONE 6:e23584. doi: 10.1371/journal.pone.0023584
133. Singh, R., and Saini, N. (2012). Down-regulation of BCL2 by miRNAs augments drug-induced apoptosis - a combined computational and experimental approach. J. Cell Sci. 125, 1568-1578.
134. Small, S. A., and Duff, K. (2008). Linking Abeta and tau in late-onset alzheimer's disease: a dual pathway hypothesis. Neuron 60, 534-542.
135. Smits, M.,Nilsson, J.,Mir, S. E.,Van Der Stoop, P. M., Hulleman, E., Niers, J. M., etal. (2010). miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis. Oncotarget 1, 710-720.
136. Sonntag, K. C. (2010). MicroRNAs and deregulated gene expression networks in neurodegeneration. Brain Res. 1338,48-57.
137. Soon, P. S., Tacon, L. J., Gill, A. J., Bam-bach, C. P., Sywak, M. S., Campbell, P. R., etal. (2009). miR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer. Clin. Cancer Res 15, 7684- 7692.
138. Spielman, L., Winger, D., Ho, L., Aisen, P. S., Shohami, E., and Pasinetti, G. M. (2002). Induction of the complement component C1qB in brain of transgenic mice with neu-ronal overexpression of human cyclo -oxygenase-2. Acta Neuropathol. 103, 157-162.
139. Spulber, G., Niskanen, E., Macdon-ald, S., Kivipelto, M., Padilla, D. F., Julkunen, V., etal. (2012). Evolution of global and local grey matter atrophy on serial MRI scans during the progression from MCI to AD. Curr. Alzheimer Res. 9, 516-524.
140. Streit, W J., Braak, H., Xue, Q. S., and Bechmann, I. (2009). Dys-trophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol. 118, 475-485.
141. Strillacci, A., Griffoni, C., Sansone, P., Paterini, P., Piazzi, G., Lazzarini, G., etal. (2009). MiR-101 downregula-tion is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp. Cell Res. 315, 1439-1447.
142. Su, H., Yang, J. R., Xu, T., Huang, J., Xu, L., Yuan, Y., et al. (2009). MicroRNA-101, down-regulated in hepatocellu-lar carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res. 69, 1135-1142.
143. Howlader, N., Noone, A. M., Krap-cho, M., Neyman, N., Aminou, R., Altekruse, S. F., etal. (eds). (2012). SEER Cancer Statistics Review 1975-2009 (Vintage 2009 Populations). Bethesda, MD: National Cancer Institute.
144. Tabares-Seisdedos, R., Dumont, N., Baudot, A., Valderas, J. M., Climent, J., Valencia, A., etal. (2011). No paradox, no progress: inverse cancer comorbidity in people with other complex diseases. Lancet Oncol. 12, 604-608.
145. Taganov, K. D., Boldin, M. P., Chang, K. J., and Baltimore, D. (2006). NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U.S.A. 103, 12481-12486.
146. Tanaka, N., Toyooka, S., Soh, J., Kubo, T., Yamamoto, H., Maki, Y., et al. (2012). Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer. Lung Cancer 76, 32-38.
147. Thu, K. L., Chari, R., Lockwood, W. W., Lam, S., and Lam, W. L. (2011). miR-101 DNA copy loss is a prominent subtype specific event in lung cancer. J. Thorac. Oncol. 6, 1594-1598.
148. Tian, T., Xu, Y., Dai, J., Wu, J., Shen, H., and Hu, Z. (2010). Functional polymorphisms in two pre-microRNAs and cancer risk: a meta-analysis. Int. J. Mol. Epidemiol. Genet. 1, 358-366.
149. Ujifuku, K., Mitsutake, N., Takakura, S., Matsuse, M., Saenko, V., Suzuki, K., etal. (2010). miR-195, miR-455-3p and miR-10a(*) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells. Cancer Lett. 296,241-248.
150. Vadnal, J., Houston, S., Bhatta, S., Freeman, E., and Mcdonough, J. (2012). Transcriptional signatures mediated by acetylation overlap with early-stage Alzheimer's disease. Exp. Brain Res. 221,287-297.
151. Vagnucci,A.H.Jr.,andLi,W.W. (2003). Alzheimer's disease and angiogenesis. Lancet 361, 605-608.
152. van Swieten, J. C., and Heutink, P. (2008). Mutations in progran-ulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia. Lancet Neurol. 7, 965-974.
153. Varambally, S., Cao, Q., Mani, R. S., Shankar, S., Wang, X., Ateeq, B., et al. (2008). Genomic loss of microRNA-101leadstooverexpressionofhistone methyltransferase EZH2 in cancer. Science 322, 1695-1699.
154. Vendramini-Costa, D. B., and Carvalho, J. E. (2012). Molecular link mechanisms between inflammation and cancer. Curr. Pharm. Des. 18, 3831-3852.
155. Vesely, M. D., Kershaw, M. H., Schreiber, R. D., and Smyth, M. J. (2011). Natural innate and adaptive immunity to cancer. Annu. Rev. Immunol. 29, 235-271.
156. Vilardo, E., Barbato, C., Ciotti, M., Cogoni, C., and Ruberti, F. (2010). MicroRNA-101 regulates amyloid precursor protein expression in hip-pocampal neurons. J. Biol. Chem. 285,18344-18351.
157. Wang, H. J., Ruan, H. J., He, X. J., Ma, Y. Y., Jiang, X. T., Xia, Y. J., et al. (2010a). Micro RNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur. J. Cancer 46, 2295-2303.
158. Wang, J., Bi, J., Liu, X., Li, K., Di, J., and Wang, B. (2012a). Has-miR-146a polymorphism (rs2910164) and cancer risk: a meta-analysis of 19 case-control studies. Mol. Biol. Rep. 39,4571-4579.
159. Wang, W. X., Huang, Q., Hu, Y., Stromberg, A. J., and Nelson, P. T. (2011). Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol. 121, 193-205.
160. Wang, W X., Kyprianou, N., Wang, X., and Nelson, P. T. (2010b). Dys-regulation of the mitogen granulin in human cancer through the miR-15/107 microRNA gene group. Cancer Res. 70,9137-9142.
161. Wang, W. X., Rajeev, B. W., Stromberg, A. J., Ren, N., Tang, G., Huang, Q., etal. (2008a). The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J. Neurosci. 28,1213-1223.
162. Wang, X., Tang, S., Le, S. Y., Lu, R., Rader, J. S., Meyers, C., et al. (2008b). Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS ONE 3:e2557. doi: 10.1371/journal.pone.0002557
163. Wang, X., Wang, J., Ma, H., Zhang, J., and Zhou, X. (2012b). Downreg-ulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer. Med. Oncol. 29,919-927.
164. Watson, G. S., and Craft, S. (2003). The role of insulin resistance in the patho-genesis of Alzheimer's disease: implications for treatment. CNS Drugs 17, 27-45.
165. Whitmer, R. A. (2007). Type 2 diabetes and risk of cognitive impairment and dementia. Curr. Neurol. Neurosci. Rep. 7, 373-380.
166. Williams, A. H., Valdez, G., Moresi, V., Qi, X., Mcanally, J., Elliott, J. L., et al. (2009). MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326, 1549-1554.
167. Wilting, S. M., Snijders, P. J., Verlaat, W., Jaspers, A., Van De Wiel, M. A., Van Wieringen, W. N., etal. (2012). Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis. Oncogene. doi: 10.1038/onc.2012.20 [Epub ahead of print].
168. Wu, M., Jolicoeur, N., Li, Z., Zhang, L., Fortin, Y., L'Abbe, D., etal. (2008). Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs. Carcinogenesis 29, 1710-1716.
169. Xia, H. F., He, T. Z., Liu, C. M., Cui, Y., Song, P. P., Jin, X. H., etal. (2009). MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf. Cell. Physiol. Biochem. 23, 347-358.
170. Xiong, Y., Fang, J. H., Yun, J. P., Yang, J., Zhang, Y., Jia, W H., etal. (2010). Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatol-ogy 51, 836-845.
171. Xu, J., Liao, X., Lu, N., Liu, W., and Wong, C. W (2011). Chromatin-modifying drugs induce miRNA-153 expression to suppress Irs-2 in glioblastoma cell lines. Int. J. Cancer 129,2527-2531.
172. Xu, J., Liao, X., and Wong, C. (2010). Downregulations of B-cell lym-phoma 2 and myeloid cell leukemia sequence 1 by microRNA 153 induce apoptosis in a glioblastoma cell line DBTRG-05MG. Int. J. Cancer 126, 1029-1035.
173. Xu, T., Zhu, Y., Xiong, Y., Ge, Y Y., Yun, J. P., and Zhuang, S. M. (2009). MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology 50, 113-121.
174. Yamakuchi, M., Lotterman, C. D., Bao, C., Hruban, R. H., Karim, B., Mendell, J. T., etal. (2010). P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 107, 6334-6339.
175. Yuva-Aydemir, Y., Simkin, A., Gascon, E., and Gao, F. B. (2011). MicroRNA-9: functional evolution of aconserved small regulatory RNA. RNA Biol. 8, 557-564.
176. Zanette, D. L., Rivadavia, F., Molfetta, G. A., Barbuzano, F. G., Proto-Siqueira, R., Silva, W. A. Jr., etal. (2007). miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. Braz. J. Med. Biol. Res. 40, 1435-1440.
177. Zeng, Y., Sun, Q. M., Liu, N. N., Dong, G. H., Chen, J., Yang, L., etal. (2010). Correlation between pre-miR-146a C/G polymorphism and gastric cancer risk in Chinese population. World J. Gastroenterol. 16, 3578-3583.
178. Zetterberg, M., Landgren, S., Anders-son, M. E., Palmer, M. S., Gustafson, D. R., Skoog, I., etal. (2008). Association of complement factor H Y402H gene polymorphism with Alzheimer's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147, 720-726.
179. Zhang, B., Pan, X., Cobb, G. P., and Anderson, T. A. (2007). microRNAs as oncogenes and tumor suppressors. Dev. Biol. 302, 1-12.
180. Zhang, J. G., Guo, J. F., Liu, D. L., Liu, Q., and Wang, J. J. (2011a). MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2. J. Thorac. Oncol. 6, 671-678.
181. Zhang, Q. Q., Xu, H., Huang, M. B., Ma, L. M., Huang, Q. J., Yao, Q., etal. (2012). MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion. Neuro Oncol. 14,278-287.
182. Zhang, T., Liu, M., Wang, C., Lin, C., Sun, Y., and Jin, D. (2011b). Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression. Anticancer Res. 31, 3859- 3863.
183. Zhao, J. J., Lin, J., Lwin, T., Yang, H., Guo, J., Kong, W., etal. (2010). microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood 115, 2630-2639.
184. Zhu, H. C., Wang, L. M., Wang, M., Song, B., Tan, S., Teng, J. F., etal. (2012a). MicroRNA-195 downreg-ulates Alzheimer's disease amyloid-|3 production by targeting BACE1. Brain Res. Bull. 88, 596-601.
185. Zhu, L., Chen, H., Zhou, D., Li, D., Bai, R., Zheng, S., etal. (2012b). MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility. Med. Oncol. 29, 1037-1043.